The first eletrocnic Journal of Otolaryngology in the world
ISSN: 1809-9777

E-ISSN: 1809-4864

 
1891 

Year: 2014  Vol. 18   Num. 3  - July/Sept - (12º)
DOI: 10.1055/s-0034-1376885
Section: Original Article
 
Treatment Model in Children with Speech Disorders and Its Therapeutic Efficiency
Author(s):
Luciana Barberena, Márcia Keske-Soares, Taís Cervi, Mariane Brandão
Key words:
speech - articulation disorders - speech language and hearing sciences - speech therapy - generalization
Abstract:

Introduction: Speech articulation disorders affect the intelligibility of speech. Studies on therapeutic models show the effectiveness of the communication treatment.

Objective: To analyze the progress achieved by treatment with the ABAB-Withdrawal and Multiple Probes Model in children with different degrees of phonological disorders.

Methods: The diagnosis of speech articulation disorder was determined by speech and hearing evaluation and complementary tests. The subjects of this research were eight children, with the average age of 5:5. The children were distributed into four groups according to the degrees of the phonological disorders, based on the percentage of correct consonants, as follows: severe, moderate to severe, mild to moderate, and mild. The phonological treatment applied was the ABAB-Withdrawal and Multiple Probes Model. The development of the therapy by generalization was observed through the comparison between the two analyses: contrastive and distinctive features at the moment of evaluation and reevaluation.

Results: The following types of generalization were found: to the items not used in the treatment (other words), to another position in the word, within a sound class, to other classes of sounds, and to another syllable structure.

Conclusion: The different types of generalization studied showed the expansion of production and proper use of therapy-trained targets in other contexts or untrained environments. Therefore, the analysis of the generalizations proved to be an important criterion to measure the therapeutic efficacy.

All right reserved. Prohibited the reproduction of papers
without previous authorization of FORL © 1997- 2024